New molecular approches using AR, FOXA1 and HER2 for outcome classification of estrogen Receptor-Positive (ER+) breast cancers”
Here, we studied new prognostic and predictive easy access strategies in breast cancer (molecular markers), for better classify ER+ breast cancer disease, which might provide additional information and be complementary to the clasical clinical-pathological prediction models.
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2018
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- spa
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/18932
- Acceso en línea:
- https://doi.org/10.48713/10336_18932
http://repository.urosario.edu.co/handle/10336/18932
- Palabra clave:
- Breast cancer
Androgen Receptor
Estrogen Receptor
Prognosis
Molecular medicine
Enfermedades
Breast cancer
Androgen Receptor
Estrogen Receptor
Prognosis
Molecular medicine
Neoplasias de la mama
Receptores androgénicos
Medicina molecular
- Rights
- License
- Atribución-NoComercial-SinDerivadas 2.5 Colombia
| Summary: | Here, we studied new prognostic and predictive easy access strategies in breast cancer (molecular markers), for better classify ER+ breast cancer disease, which might provide additional information and be complementary to the clasical clinical-pathological prediction models. |
|---|